Evidence map›Paper›PMID 36806371›Full record

ArticleNature reviews. Nephrology2023

Reply to 'Use of convalescent plasma in the treatment of COVID-19'.

Naoka Murakami, Robert Hayden, Thomas Hills, Hanny Al-Samkari, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan Sise, David E Leaf

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature reviews. Nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Naoka MurakamiDivision of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0001-8168-5811
Robert HaydenDivision of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Thomas HillsMedical Research Institute of New Zealand, Wellington, New Zealand.ORCID 0000-0003-0322-5822
Hanny Al-SamkariHarvard Medical School, Boston, MA, USA.ORCID 0000-0001-6175-1383
Jonathan CaseyDivision of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Lorenzo Del SorboDepartment of Medicine, University Health Network, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
Patrick R LawlerDepartment of Medicine, University Health Network, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
Meghan SiseHarvard Medical School, Boston, MA, USA.
David E LeafDivision of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA. deleaf@bwh.harvard.edu.ORCID 0000-0001-7875-090X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 SerotherapyHumansSARS-CoV-2Treatment Outcome

Identifiers

PMID36806371
PMCPMC9937737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.